1887

Cytarabine (Cytosine arabinoside, Ara-C)

This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition
  1. Marconato L, Bonfanti U, Stefanello D et al. (2008) Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?Veterinary Comparative Oncology 6, 80–89
  2. Zarfoss M ,Schatzberg S ,Venator K et al.(2006)Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs. Journal of Small Animal Practice 47 ,588595
  3. Alvarez FJ, Kisseberth WC, Gallant SL and Couto CG (2006) Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma.Journal of Veterinary Internal Medicine20, 1178–1183
  4. Lowrie M, Thomson S, Smith P and Garosi L (2016) Effect of a constant rate infusion of cytosine arabinoside on mortality in dogs with meningoencephalitis of unknown origin. The Veterinary Journal 213 1–5
  5. Ruslander D ,Moore AS ,Gliatto JM et al. (1994)Cytosine arabinoside as a single agent for the induction of remission in canine lymphoma. Journal of Veterinary Internal Medicine 8 ,299301
  6. Smallwood K, Harper A and Blackwood L (2021) Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. Journal of Feline Medicine and Surgery 23, 722–729
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error